NCT05614726View on ClinicalTrials.gov

A Probiotic Blend Reduces Gastrointestinal Symptoms and Positively Impacts Microbiota Modulation in a Randomized Study

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

March 17, 2022

Study Completion Date

March 17, 2022

Conditions
MicrobiotaConstipationCandida
Interventions
DIETARY_SUPPLEMENT

575mg [30 billion colony forming units] probiotic blend of Bifidobacterium breve, Lactobacillus acidophilus, Lacticaseibacillus rhamnosus, Saccharomyces boulardii, and alpha amylase

A multi-strain probiotic blend

Trial Locations (1)

44406

The Center for Applied Health Sciences, Canfield

All Listed Sponsors
collaborator

Biohm Health, LLC

UNKNOWN

lead

The Center for Applied Health Sciences, LLC

INDUSTRY